Literature DB >> 6538712

Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities.

A B Einstein, W Shipley, J Coombs, K B Cummings, M S Soloway, I Hawkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6538712     DOI： 10.1016/s0090-4295(84)80080-1

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  5 in total

Review 1.  [Value of systemic chemotherapy in bladder cancer].

Authors:  P J Goebell; F vom Dorp; H Rübben
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

2.  Adjuvant chemotherapy for invasive bladder cancer.

Authors:  Y Uekado; T Shinka; A Hirano; T Ohkawa
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Results of adjuvant chemotherapy for invasive uroepithelial cancer.

Authors:  Y Uekado; A Hirano; T Shinka; T Ohkawa
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 4.  Adjuvant chemotherapy for invasive bladder cancer (individual patient data).

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 5.  Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials.

Authors: 
Journal:  Eur Urol       Date:  2021-11-19       Impact factor: 20.096
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.